Pegaptanib sodium

Details

Files

Generic Name:

Pegaptanib sodium

Project Status:

Complete

Therapeutic Area:

Macular degeneration, age-related

Manufacturer:

Pfizer Canada Inc.

Brand Name:

Macugen

Project Line:

Reimbursement Review

Project Number:

SR0044-000

Submission Type:

Initial

Indications:

Macular degeneration, age-related

Recommendation Type:

Do not list

Final Recommendation:

May 25, 2006

Recommendation:

(tentative)

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : October 20, 2005